Search results

Skip to results

Area of interest

Area of interest

Type

Type

Status

Status

Last updated

Last updated

Guidance programme

Advice programme

Showing 2626 to 2640 of 9025 results

  1. Melphalan chemosaturation with percutaneous hepatic artery perfusion and hepatic vein isolation for primary or metastatic cancer in the liver

    In development Reference number: GID-IPG10448 Expected publication date:  15 October 2026

  2. Inavolisib with palbociclib and fulvestrant for treating recurrent hormone receptor-positive HER2-negative PIK3CA-positive advanced breast cancer after adjuvant endocrine treatment [ID6425]

    In development Reference number: GID-TA11519 Expected publication date: TBC

  3. Somapacitan for treating growth failure caused by Turner syndrome in people 2 to 17 years [ID6621]

    Awaiting development Reference number: GID-TA11821 Expected publication date: TBC

  4. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6413]

    In development Reference number: GID-TA11488 Expected publication date: TBC

  5. Tafasitamab with lenalidomide and rituximab for treating relapsed or refractory follicular lymphoma after 1 or more systemic treatments [ID6413]: draft guidance

    We are listening to your views on this Technology appraisal guidance. Comments close 17 June 2026.

  6. Image-guided high intensity focused ultrasound to treat breast cancer

    Topic prioritisation

  7. Digital flexor tenotomy for diabetic foot

    Topic prioritisation

  8. Transcatheter Tricuspid Valve Replacement

    Topic prioritisation

  9. Transcatheter valve-in-valve implantation for the treatment of Tricuspid valve

    Topic prioritisation

  10. Endovascular stent insertion for intracranial atherosclerotic disease

    Topic prioritisation

  11. Intravascular Lithotripsy-Enabled Vascular Access for Transfemoral Transcatheter Aortic Valve Replacement

    Topic prioritisation

  12. CFHealthHub for managing cystic fibrosis during the COVID-19 pandemic

    Topic prioritisation

  13. d-NAV for optimization of personal insulin management in adults with type 2 diabetes (MT696)

    Topic prioritisation

  14. Telmisartan–amlodipine–indapamide for untreated hypertension TS ID 12034

    Topic prioritisation